Diagnostic tools: Various tests to diagnose and manage
hepatitis C including various biochemical marker, imaging, liver biopsy for
grading/staging liver disease and HCV RNA (viral load) tests.
·
Biochemical/Imaging
o
437. Point Of Care Non-Invasive
13C Methacetin Breath Testing Accurately Identifies Significant Liver
Inflammation and Fibrosis: A Novel Method For Assessing Liver Damage
o S1000. Identification of Novel
Biomarker Profiles in Hepatitis C Positive Liver Cancer Patients. (updated,
May 20)
·
General
o 585. Elevated levels of circulating mesenchymal stem cells in patients with
chronic hepatitis B and C.
·
Non-invasive markers
o M1833. Investigating the Cause
of High Ast/Alt Ratio in HCV-Induced Liver Cirrhosis.
o M1842. Transient elastography in
chronic hepatitis B and C predicts severe fibrosis similarly.
o M1844. Point of Care
Non-Invasive 13C Methacetin Breath Testing Accurately Identifies Significant
Liver Inflammation and Fibrosis: A Novel Method For Assessing Liver Damage. (updated,
May 21)
o S1004. A Comparison of
Alphafetoprotein, AFP-L3% and Des-Gamma Carboxyprothrombin in Patients with
Chronic Hepatitis, Cirrhosis and Hepatocellular Carcinoma. (updated,
May 20)